Methylsulfonylmethane Joint Pain Meta-analysis: What the Evidence Says

Quick Answer

Methylsulfonylmethane Joint Pain Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Effective management of KOA is therefore crucial not only for improving the patient's quality of life but also for reducing the associated economic burden. [Sumsuzzman Dewan Md. (2024); evidence level 1]
• Managing KOA pain mainly relies on NSAIDs, but their prolonged use raises the risk of gastrointestinal and cardiovascular adverse events. [Sumsuzzman Dewan Md. (2024); evidence level 1]
• Another worldwide study found that the prevalence was almost 29.5% and that women are more likely to be affected than men. [Gazali Mohammad (2026); evidence level 3]
• Psychological interventions, such as cognitive-behavioral therapy, are gaining popularity for their effectiveness when used in conjunction with biomedical treatments, indicating that a holistic approach can produce substantial result. [Gazali Mohammad (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For methylsulfonylmethane joint pain meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Sumsuzzman Dewan Md. (2024). Comparative Efficacy of Glucosamine-Based Combination Therapies in Alleviating Knee Osteoarthritis Pain: A Systematic Review and Network Meta-Analysis. DOI: 10.3390/jcm13237444. PMCID: PMC11641979. PMID: 39685902. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC11641979/
• Gazali Mohammad (2026). Diagnosis-based pathways for conservative and minimally invasive management of temporomandibular disorders: a scoping review. DOI: 10.22514/jofph.2026.034. PMCID: PMC13223916. PMID: 42220286. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13223916/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.